Kidney Transplantation Therapeutics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2024-2028

Published: Jan 2024

Pages: 171

SKU: IRTNTR73275

Snapshot

Kidney Transplantation Therapeutics Market 2024-2028

The global kidney transplantation therapeutics market size is estimated to grow by USD 643.15 million, at a CAGR of 4.49% between 2023 and 2028.

The kidney transplantation therapeutics market has witnessed significant advances in surgical techniques and ancillary healthcare techniques in recent years. Such advances are increasing the demand for kidney transplantation. However, graft rejection is a major challenge associated with kidney transplantation. However, to overcome this challenge, vendors have developed immunosuppressants. Patients are required to undergo maintenance therapy using these immunosuppressants for the rest of their lives to reduce the risk and probability of the transplanted organ getting rejected by the body. Therefore, the increasing number of cases of kidney transplantation and the risks associated with transplant rejection are expected to fuel the demand for immunosuppressants, which will drive the growth of the market during the forecast period.

Technavio has segmented the market into Product, Distribution Channel, and Geography

The product segment includes selective cytokine inhibitors, immunosuppressive antimetabolites, and other drug
The distribution channel segment includes hospital pharmacy, retail pharmacy, and online pharmacy
The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.

What will be the size of the Kidney Transplantation Therapeutics Market During the Forecast Period?

To learn more about this report, Download Report Sample

Kidney Transplantation Therapeutics Market Segmentation by Product, Distribution Channel, and Geography Analysis

Product Analysis

Selective cytokine inhibitors

The market share growth by the selective cytokine inhibitors segment will be significant during the forecast period. The segment involves the use of drugs that inhibit the production and function of cytokines. Cytokines are cell signaling molecules that help in mediating immune response signals from one cell to another and stimulate the movement of immune cells toward a foreign object. These immune cells include interleukins (ILs), interferons (IFNs), tumor necrosis factors (TNFs), colony-stimulating factors (CSFs), and transforming growth factors.

Get a glance at the market contribution of various segments Download PDF Sample

The selective cytokine inhibitors segment was valued at USD 1,039.94 million in 2018. Selective cytokine inhibitors have superior immunosuppressive activity compared with those belonging to other drug classes. Furthermore, the availability of tacrolimus in multiple dosage forms provides the option to adjust the dose as per a patient's needs. Due to these factors, the selective cytokine inhibitors segment of the global kidney transplantation market is expected to grow during the forecast period.

Distribution Channel Analysis

Hospital pharmacy

The distribution of kidney transplantation therapeutics through hospital pharmacies offers several benefits, contributing to the overall efficiency and effectiveness of the kidney transplantation process. Hospital pharmacies are often located within the hospital itself, making it easier for patients to obtain their medications after transplant surgery. In addition, hospital pharmacies can collaborate closely with transplant teams, fostering communication and coordination among healthcare providers. Hospital pharmacists often have specialized knowledge in transplant pharmacotherapy, ensuring that patients receive medications tailored to their specific needs. Hence, factors such as streamlined access to medication, reduced administrative burden, and improved communication and collaboration will boost the growth of the hospital pharmacy segment and promote market growth during the forecast period.

Retail pharmacy

Retail pharmacies are often conveniently located, making it easier for transplant recipients to access their medications close to home. Retail pharmacies operate extended hours, including evenings and weekends. This extended accessibility ensures that patients can obtain their kidney transplantation medications outside of regular business hours, enhancing flexibility for those with busy schedules. Further, retail pharmacies are integrated with electronic health record systems, allowing seamless communication between healthcare providers and pharmacists. This integration supports better coordination of care, including medication adjustments and monitoring. Therefore, such factors will drive the growth of the retail pharmacy segment and promote market growth during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 45% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America has a significant prevalence of kidney diseases, including chronic kidney disease (CKD) and end-stage renal disease (ESRD). The rising incidence of these conditions contributes to an increased demand for kidney transplantation and associated therapeutics. The region benefits from advanced healthcare facilities, including state-of-the-art transplant centers, specialized nephrology units, and well-equipped hospitals.

Additionally, the pharmaceutical industry in North America is robust, with numerous companies actively engaged in the development and commercialization of drugs for kidney transplantation. The presence of key pharmaceutical players contributes to the availability of therapeutic options. Furthermore, the aging population in North America is more susceptible to kidney-related disorders. As the elderly population grows, the demand for kidney transplantation therapeutics is likely to increase, given the higher prevalence of kidney diseases in this demographic. Thus, such factors will drive the growth of the regional market during the forecast period.

Buy Full Report Now

Key Kidney Transplantation Therapeutics Market Players

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

AbbVie Inc.: The company offers kidney transplantation therapeutics such as 2.0 Synopsis.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Kidney Transplantation Therapeutics Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges.

Key Kidney Transplantation Therapeutics Market Drivers

The rising prevalence of CKD and renal impairments is the key factor driving market growth. Owing to the increasing number of cases of non-communicable diseases and their risk factors, the burden of CKD is increasing worldwide. CKD affects almost 8.5%-9.5% of the adult population globally. Diabetes, hypertension, vascular disease, and glomerulonephritis are some of the major causes of CKD. In most underdeveloped and developing countries, glomerulonephritis and interstitial nephritis are the two major causes of CKD, owing to the high prevalence of infections.

Furthermore, studies have revealed that CKD causes significant impairment of quality of life and decreases life expectancy at all ages. It is also associated with an increased risk of cardiovascular diseases, infections, diabetes, and cancer. Thus, the rising prevalence of CKD and renal impairments is expected to increase the need for kidney transplantation, which will drive the growth of the global kidney transplantation therapeutics market during the forecast period.

Significant Kidney Transplantation Therapeutics Market Trends

Increasing strategic alliances is the primary trend shaping market growth. The drug development process aligns with market trends and analysis requires a highly advanced R&D team, which most mid-sized and small pharmaceutical companies lack. Many small and mid-sized vendors do not achieve economies of scale, which affects their profits. To overcome these challenges, market players are entering into strategic alliances. For example, Veloxis Pharmaceuticals, the manufacturer of ENVARSUS XR, has a strong regional presence in Europe and an established distribution network in the US.

Similarly, the market also witnesses vendors getting into partnership agreements for the development of kidney transplantation therapeutics. For example, Roche and Aspreva Pharmaceuticals Corp. codeveloped CellCept, one of the most commonly used immunosuppressants for the prevention of kidney transplant rejection. Market players are also forming collaborations with academic institutions for the development of novel therapeutics. Thus, such factors are expected to drive market growth during the forecast period.

Major Kidney Transplantation Therapeutics Market Challenges

The demand-supply imbalance for kidney transplantation is a challenge that affects market growth. Although the incidence of kidney failure has been increasing significantly, owing to the rising prevalence of various renal indications, the market faces a threat from the shortage of kidneys to be transplanted. For instance, as per the National Kidney Foundation Inc. (National Kidney Foundation), CKD is prevalent in approximately 10% of the global population, and the mortality rate of the indication is increasing each year. The primary cause of death in patients with CKD is the lack of access to affordable treatment, including kidney transplantation.

The lack of kidneys available for transplantation is resulting in a surge in the number of patients on the waiting list, which is increasing the mortality rates among patients with kidney failure. Furthermore, despite the increasing number of awareness campaigns on organ donation, with a primary focus on kidney donation, to address the unmet need that currently exists, the market still witnesses a heavy gap between the need and the availability of kidneys. Thus, such factors will decline the growth of the market in focus during the forecast period.

Buy Now Full Report

Key Kidney Transplantation Therapeutics Market Customer Landscape

The market report includes the adoption lifecycle of the market growth and forecasting, covering from the innovator’s stage to the laggard’s stage. The market analysis and report focus on adoption rates in different regions based on penetration. Furthermore, market research and growth report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Kidney Transplantation Therapeutics Market Customer Landscape

Segment Overview

The kidney transplantation therapeutics market report forecasts market growth analysis by revenue at global, regional & country levels and provides an analysis of the latest market growth and trends from 2018 to 2028.

Product Outlook
- Selective cytokine inhibitors
- Immunosuppressive antimetabolites
- Other drug

Distribution Channel Outlook
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy

Region Outlook
- North America
  - The U.S.
  - Canada
- Europe
  - The U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
- Rest of World (ROW)
  - Argentina
  - Australia
  - Brazil

Kidney Transplantation Therapeutics Market Scope
Report Coverage	Details
Page number	171
Base year	2023
Historic period	2018-2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 4.49%
Market Growth 2024-2028	USD 643.15 million
Market structure	Fragmented
YoY growth 2023-2024(%)	4.05
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 45%
Key countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
Key companies profiled	AbbVie Inc., Asahi Kasei Corp., Astellas Pharma Inc., B.Braun SE, Bristol Myers Squibb Co., Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Fresenius Medical Care AG and Co. KGaA, GlaxoSmithKline Plc, Hansa Biopharma AB, Novartis AG, Organ Recovery Systems Inc., Pfizer Inc., Sanofi SA, Strides Pharma Science Ltd., TFF Pharmaceuticals Inc., TolerogenixX GmbH, TransMedics Inc., and Transonic Systems Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Kidney Transplantation Therapeutics Market Research Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the kidney transplantation therapeutics market forecast between 2024 and 2028
Precise estimation of the kidney transplantation therapeutics market size and its contribution to the market in focus on the parent market
Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria
Companies landscape comparing criticality of inputs and factors of differentiation
Exclusive Matrix on companies' position and classification
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
A thorough analysis of the market’s competitive landscape and detailed information about companies
Comprehensive analysis of factors that will challenge the growth of kidney transplantation therapeutics market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global kidney transplantation therapeutics market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global kidney transplantation therapeutics market 2018 - 2022 ($ million)

4.2 Product Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Product Segment 2018 - 2022 ($ million)

4.3 Distribution Channel Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ million)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
- Exhibit 30: Chart on Product - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Product - Market share 2023-2028 (%)

6.2 Comparison by Product
- Exhibit 32: Chart on Comparison by Product
- Exhibit 33: Data Table on Comparison by Product

6.3 Selective cytokine inhibitors - Market size and forecast 2023-2028
- Exhibit 34: Chart on Selective cytokine inhibitors - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Selective cytokine inhibitors - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Selective cytokine inhibitors - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Selective cytokine inhibitors - Year-over-year growth 2023-2028 (%)

6.4 Immunosuppressive antimetabolites - Market size and forecast 2023-2028
- Exhibit 38: Chart on Immunosuppressive antimetabolites - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Immunosuppressive antimetabolites - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Immunosuppressive antimetabolites - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Immunosuppressive antimetabolites - Year-over-year growth 2023-2028 (%)

6.5 Other drug - Market size and forecast 2023-2028
- Exhibit 42: Chart on Other drug - Market size and forecast 2023-2028 ($ million)
- Exhibit 43: Data Table on Other drug - Market size and forecast 2023-2028 ($ million)
- Exhibit 44: Chart on Other drug - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Other drug - Year-over-year growth 2023-2028 (%)

6.6 Market opportunity by Product
- Exhibit 46: Market opportunity by Product ($ million)
- Exhibit 47: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Distribution Channel

7.1 Market segments
- Exhibit 48: Chart on Distribution Channel - Market share 2023-2028 (%)
- Exhibit 49: Data Table on Distribution Channel - Market share 2023-2028 (%)

7.2 Comparison by Distribution Channel
- Exhibit 50: Chart on Comparison by Distribution Channel
- Exhibit 51: Data Table on Comparison by Distribution Channel

7.3 Hospital pharmacy - Market size and forecast 2023-2028
- Exhibit 52: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)

7.4 Retail pharmacy - Market size and forecast 2023-2028
- Exhibit 56: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 57: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 58: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)

7.5 Online pharmacy - Market size and forecast 2023-2028
- Exhibit 60: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 61: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 62: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)

7.6 Market opportunity by Distribution Channel
- Exhibit 64: Market opportunity by Distribution Channel ($ million)
- Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 67: Chart on Market share by geography 2023-2028 (%)
- Exhibit 68: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 69: Chart on Geographic comparison
- Exhibit 70: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 China - Market size and forecast 2023-2028
- Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)

9.9 Canada - Market size and forecast 2023-2028
- Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.10 Germany - Market size and forecast 2023-2028
- Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.11 UK - Market size and forecast 2023-2028
- Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 107: Market opportunity by geography ($ million)
- Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 109: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 110: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 111: Overview on factors of disruption

11.4 Industry risks
- Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 113: Vendors covered

12.2 Market positioning of vendors
- Exhibit 114: Matrix on vendor position and classification

12.3 AbbVie Inc.
- Exhibit 115: AbbVie Inc. - Overview
- Exhibit 116: AbbVie Inc. - Product / Service
- Exhibit 117: AbbVie Inc. - Key news
- Exhibit 118: AbbVie Inc. - Key offerings

12.4 Asahi Kasei Corp.
- Exhibit 119: Asahi Kasei Corp. - Overview
- Exhibit 120: Asahi Kasei Corp. - Business segments
- Exhibit 121: Asahi Kasei Corp. - Key news
- Exhibit 122: Asahi Kasei Corp. - Key offerings
- Exhibit 123: Asahi Kasei Corp. - Segment focus

12.5 Astellas Pharma Inc.
- Exhibit 124: Astellas Pharma Inc. - Overview
- Exhibit 125: Astellas Pharma Inc. - Product / Service
- Exhibit 126: Astellas Pharma Inc. - Key news
- Exhibit 127: Astellas Pharma Inc. - Key offerings

12.6 Bristol Myers Squibb Co.
- Exhibit 128: Bristol Myers Squibb Co. - Overview
- Exhibit 129: Bristol Myers Squibb Co. - Product / Service
- Exhibit 130: Bristol Myers Squibb Co. - Key news
- Exhibit 131: Bristol Myers Squibb Co. - Key offerings

12.7 Dr Reddys Laboratories Ltd.
- Exhibit 132: Dr Reddys Laboratories Ltd. - Overview
- Exhibit 133: Dr Reddys Laboratories Ltd. - Business segments
- Exhibit 134: Dr Reddys Laboratories Ltd. - Key offerings
- Exhibit 135: Dr Reddys Laboratories Ltd. - Segment focus

12.8 F. Hoffmann La Roche Ltd.
- Exhibit 136: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 137: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 138: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 139: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 140: F. Hoffmann La Roche Ltd. - Segment focus

12.9 GlaxoSmithKline Plc
- Exhibit 141: GlaxoSmithKline Plc - Overview
- Exhibit 142: GlaxoSmithKline Plc - Business segments
- Exhibit 143: GlaxoSmithKline Plc - Key news
- Exhibit 144: GlaxoSmithKline Plc - Key offerings
- Exhibit 145: GlaxoSmithKline Plc - Segment focus

12.10 Hansa Biopharma AB
- Exhibit 146: Hansa Biopharma AB - Overview
- Exhibit 147: Hansa Biopharma AB - Product / Service
- Exhibit 148: Hansa Biopharma AB - Key offerings

12.11 Novartis AG
- Exhibit 149: Novartis AG - Overview
- Exhibit 150: Novartis AG - Business segments
- Exhibit 151: Novartis AG - Key offerings
- Exhibit 152: Novartis AG - Segment focus

12.12 Organ Recovery Systems Inc.
- Exhibit 153: Organ Recovery Systems Inc. - Overview
- Exhibit 154: Organ Recovery Systems Inc. - Product / Service
- Exhibit 155: Organ Recovery Systems Inc. - Key offerings

12.13 Pfizer Inc.
- Exhibit 156: Pfizer Inc. - Overview
- Exhibit 157: Pfizer Inc. - Product / Service
- Exhibit 158: Pfizer Inc. - Key news
- Exhibit 159: Pfizer Inc. - Key offerings

12.14 Sanofi SA
- Exhibit 160: Sanofi SA - Overview
- Exhibit 161: Sanofi SA - Business segments
- Exhibit 162: Sanofi SA - Key news
- Exhibit 163: Sanofi SA - Key offerings
- Exhibit 164: Sanofi SA - Segment focus

12.15 Strides Pharma Science Ltd.
- Exhibit 165: Strides Pharma Science Ltd. - Overview
- Exhibit 166: Strides Pharma Science Ltd. - Business segments
- Exhibit 167: Strides Pharma Science Ltd. - Key offerings
- Exhibit 168: Strides Pharma Science Ltd. - Segment focus

12.16 TFF Pharmaceuticals Inc.
- Exhibit 169: TFF Pharmaceuticals Inc. - Overview
- Exhibit 170: TFF Pharmaceuticals Inc. - Product / Service
- Exhibit 171: TFF Pharmaceuticals Inc. - Key offerings

12.17 TolerogenixX GmbH
- Exhibit 172: TolerogenixX GmbH - Overview
- Exhibit 173: TolerogenixX GmbH - Product / Service
- Exhibit 174: TolerogenixX GmbH - Key offerings

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 175: Inclusions checklist
- Exhibit 176: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 177: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 178: Research methodology
- Exhibit 179: Validation techniques employed for market sizing
- Exhibit 180: Information sources

13.5 List of abbreviations
- Exhibit 181: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

kidney transplantation therapeutics market market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis